baber/WOPTO huggingface dataset:
Patent FI-950439-A0 (FI)
Inventor: DUNN JAMES M
IPC: A61K9/22
Filed: 1995-02-01
Abstract: PCT No. PCT/US93/07308 Sec. 371 Date Mar. 27, 1995 Sec. 102(e) Date Mar. 27, 1995 PCT Filed Aug. 4, 1993 PCT Pub. No. WO94/03471 PCT Pub. Date Feb. 17, 1994This invention is directed to controlled release pharmaceutical formulations of 3'-azido-3'-deoxythymidine, also known as AZT or zidovudine and methods of use thereof. The controlled release formulations of AZT achieve and maintain a therapeutic level of AZT, while substantially reducing the side effects of AZT caused by its catabolite 3'-amino-3'-deoxythymidine (AMT) by reducing the amount of AMT produced.
Patent FI-951239-A0 (FI)
Inventor: AEBISCHER PATRICK
IPC: A61K35/12
Filed: 1995-03-16
Abstract: A particulate chitosan core matrix for viable cells encapsulated in vehicles intended for implantation into an individual is taught. The matrix provides a physical support for viable cells, keeping them evenly dispersed throughout the core, thus allowing their maintenance, growth, proliferation and differentiation.
Patent FI-952021-A0 (FI)
Inventor: FLORIN-ROBERTSSON EBBA
IPC: A61K38/00
Filed: 1995-04-27
Abstract: PCT No. PCT/SE93/00885 Sec. 371 Date May 24, 1995 Sec. 102(e) Date May 24, 1995 PCT Filed Oct. 27, 1993 PCT Pub. No. WO94/10192 PCT Pub. Date May 11, 1994A process for manufacturing crystals of growth hormone (GH) comprising the steps of: i) mixing GH with an aqueous solution comprising a buffer and a chemical compound with the general formula (1): Ar-[-CR1R2-]n-[-C R3R4-]m-C R5R6-OH(1)in which Ar is phenyl, alkyl-substituted phenyl, naphthyl, or alkyl-substituted naphthyl, R1 to R6 is H, OH or alkyl and n and m is 0 or 1; ii) incubating; and iii) isolating the crystals is provided. The crystals are in the form of needles, trigonal forms, cubes or parallelepipeds with a length of at least 20 microns.
Patent FI-953771-A0 (FI)
Inventor: CHARTCHENKO IGOR
IPC: C04B28/02
Filed: 1995-08-09
Abstract: A dry mix, for producing a cement suspension for filling and/or injecting pore spaces and cavities in loose rock or cavities and/or cracks in rock or in concrete components, is in the form of a ready mix containing (a) sulphate additive-free finely ground clinker and/or smelter sand powder; (b) additives; and (c) an ettringite-forming swelling component which produces swelling during strength development of the fine cement-binder mixture while the matrix is still soft after the filling and/or injection operation. The entire homogeneous dry mix has a continuous graduated particle distribution with sieve pass values of d95 = ≤ 24 (preferably ≤ 16) microns and d50 = ≤ 7 (preferably ≤ 5) microns, the d50/d95 ratio preferably being 0.33 plus or minus 0.04. Preferably, the mix contains a naphthalene sulphonate-formaldehyde condensate as plasticiser. Also claimed are: (a) preparation of the above dry mix, in which all the components have the above defined fineness and particle distribution and are stored separately in storage silos, certain components being dosed from the corresponding silos for delivery to a mixer and the components being homogenised and mixed in the mixer to form the ready mix; and (b) apparatus for carrying out the above process, in which a storage silo (7-12) is provided for each component and is combined with a dosing device, the silos being followed by a mixer (14).
Patent FI-955724-A0 (FI)
Inventor: LJOKKOI RISTO
IPC: B01D39/12
Filed: 1995-11-28
Abstract: The present invention relates to a method of manufacturing a wire screen product which is especially suitable for screening fiber suspensions of the wood processing industry. It is a characteristic feature of the method according to the invention of manufacturing a wire screen product including screen wires disposed crosswire in relation to a support arranagement that includes at least one support wire, the screen wires and support wire being secured to each other such that, at the first stage, the screen wire is welded by a button spot weld to the support arrangement and, at the second stage, the screen wire is welded at another point to the same support structure.
Patent FI-960265-A0 (FI)
Inventor: CUSSLER EDWARD L
IPC: C07C309/67
Filed: 1996-01-19
Abstract: PCT No. PCT/IB94/00114 Sec. 371 Date Jan. 17, 1996 Sec. 102(e) Date Jan. 17, 1996 PCT Filed May 19, 1994 PCT Pub. No. WO95/03033 PCT Pub. Date Feb. 2, 1995An osmotic device that, following the imbibement of water vapor, provides for the controlled release of a beneficial agent to an aqueous environment. The device comprises a hydrophilic formulation including a beneficial agent, and if needed, an osmagent, surrounded by a wall. The wall is formed at least in part of a semipermeable hydrophobic membrane having an average pore size between about 0.1  mu m and 30  mu m. The pores are substantially filled with a gas phase. The hydrophobic membrane is permeable to water in the vapor phase and the hydrophobic membrane is impermeable to an aqueous medium at a pressure less than about 100 Pa. The beneficial agent is released, for example, by osmotic pumping or osmotic bursting upon imbibement of sufficient water vapor into the device core. These devices minimize incompatibilities between the beneficial agent and ions (such as hydrogen or hydroxyl) or other dissolved or suspended materials in the aqueous medium, since contact between the beneficial agent and the aqueous medium does not occur until after the beneficial agent is released. This results from the semipermeable membrane's selective permeability for water vapor. In addition, the high water fluxes attendant with these vapor-permeable membranes facilitate the delivery of beneficial agents having low solubilities, and the delivery of high dosages of beneficial agents.
Patent FI-961623-A0 (FI)
Inventor: DUFOUR RENEAU
IPC: F04D7/02
Filed: 1996-04-12
Abstract: Disclosed is a centrifugal liquid pump, preferably of the rotary disc type, which incorporates a gas injection assembly of very simple yet efficient structure, whereby up to 15% per volume of a gas such as air, may be mixed with the pumped liquid. The gas injection is achieved with a gas feed pipe that enters the pump through its axial inlet and with a plurality of gas injector pipes that projects from the gas feed pipe radially within the impeller.
Patent FI-961686-A0 (FI)
Inventor: LAITINEN JUKKA
IPC: H04B7/26
Filed: 1996-04-17
Abstract: The present invention relates to a base station (BTS) of a radio system comprising several receivers (RX1, RX2) and several transmitters (TX1, TX2), whereby at least one of the receivers comprises means for measuring the signal level of the received signal. In order to measure disturbances caused by intermodulation of signals of the transmitters the base station comprises testing means (3). The transmitters (TX1, TX2) are responsive to said testing means (3) for generating predetermined signals to the antenna means (1, 2). Furthermore, said receiver (RX1) is responsive to the testing means (3) for receiving signals from frequency channels (f3, f4) of the base station normally in reception use and measuring the signal level of the received signal.
Patent FI-963917-A0 (FI)
Inventor: CAVAGLIA GIULIANO
IPC: B29C48/89
Filed: 1996-09-30
Abstract: A process and an apparatus for the production of a flat mono- or multi-layer thermoplastic film (2) for packaging, comprising a flat extrusion die (1) and a chill roll (6) provided with an internal cooling system. A liquid knife device (10) is associated with said chill roll (6) for spouting a continuous and substantially uniform liquid knife (20) at a predetermined speed and temperature, said liquid knife device (10) being provided with a slot (19) which has an adjustable outflow cross section (21) and is fed with a liquid at a predetermined temperature and flow rate.
Patent AP-9200430-A0 (AP)
Title: Water sanitisation.
Inventor: BOGIE KENNETH DAVID
Filed: 1992-09-22
Abstract: The invention relates to a method of sanitising water by the in situ oxidation of halogen ions to hypohalogen ions and to the composition for use in the method. The halogen ions may be bromie ions and the oxidation may be achieved with hydrogen peroxide or monopersulphate.
Patent IL-61098-A0 (IL)
Title: New peptides and a process for their preparation
IPC: C07K7/06
Filed: 1980-09-21
Abstract: What are disclosed are pentapeptides, useful for influencing the maturing of T-lymphocytes, of the formula +TI, G-K-Q-X-M wherein G is arginine, lysine, ornithine, or homoarginine, or is an unsubstituted or substituted  omega -aminoalkanoyl,  omega -guanidinoalkanoyl, or omega -dimethylaminoalkanoyl; K is a basic amino acid such as lysine, arginine, homoarginine, or ornithine; Q is L- or D-glutamic acid, d-aspartic acid, or D- alpha -aminoadipic acid; X is L-valine or L-isoleucine; and M is an L- or D-aminoacid having a hydrophobic side chain, or an ester or amide of such an acid.
Patent IL-62551-A0 (IL)
Title: Electrophotographic color proofing apparatus
IPC: G03G13/26
Filed: 1981-04-01
Abstract: An electrophotographic color proofing apparatus including a copyboard carrying a color separated positive and capable of being positioned into intimate contact with a charged photoconductive coating of an electrophotographic member. The engaged members are exposed to light, discharging the coating in increments to form a latent electrostatic image thereon. The copyboard is withdrawn and the exposed electrophotographic member rotated 180 degrees facing toward a toning assembly consisting of a row of plural toning units, each carrying a different color toner and arranged in line for linear translation below the exposed electrophotographic member with a selected one toning unit thereof being activated to apply a selected color toner to the latent electrostatic image. The toned member again is revolved 180 degrees. A pre-wet transfer medium in the form of print paper stock is engaged with the toned member for transfer of the toned image, preferably by drawing a roller across said member while employing a simultaneous electrical bias. A full color proof can be obtained by repeating the cycle, activating successive individual toning units of the assembly and using the same sheet of transfer medium. Registry of plural images applied to a single sheet is effected mechanically, as by upstanding pins provided on the support for electrophotographic member and/or the copyboard. Provision is made to clean both the photoconductive surface and the bias plates of the toning units of excess and/or residual toner.
Patent IL-76644-A0 (IL)
Title: Salts of piroxicam
IPC: C07D417/12
Filed: 1985-10-10
Abstract: Improved antiinflammatory salts of piroxicam consist of a 1 : 1 salt of piroxicam with antidepressant doxepin, with bronchodilator pirbuterol or isoproterenol, with H<sub>2</sub>-antagonist inhibitor 2-guanidino-4-(2-methyl-4-imidazolyl)thiazole, with pyridoxine, a member of the vitamin B<sub>6</sub> complex, or with anti- hypertensive trimazosin.
Patent IL-90049-A0 (IL)
Title: Lock control assembly
IPC: E05B37/00
Filed: 1989-04-19
Abstract: A timing gear arrangement, an idler gear arrangement (21) and a code gear arrangement (35) are mounted in parallel with each other such that the timing gears are in mesh with the idler gears (53) which are in mesh with the code gears. Push buttons (7) are associated with each of the idler gears (53) on the idler gear arrangement (53), and each push button (6) is connected to a slider plate (78, 77) which will cause its associated code gear to rotate a predetermined distance when the push button (7) is depressed. Further, the code gear arrangement is removably mounted in the lock control assembly.
Patent IL-93170-A0 (IL)
Title: Carboxylic and sulphonic acid amides,their preparation and pharmaceutical compositions containing them
IPC: A61K31/381
Filed: 1990-01-25
Abstract: The novel carboxylic acid and sulphonic acid amides of the formula
 R<1>-A-(W)a-X-(CH2)b-(Y)c-B-Z-COOR     (I) in which R<1>, A, W, X, Y, B, Z, R, a, b and c have the meaning given in the description, can be used in the treatment of thromboses, apoplexy, cardiac infarcts, inflammations, arteriosclerosis and tumours. They are prepared by removal of the protective groups in corresponding compounds having protected amidino or guanidino groups.
Patent IL-93748-A0 (IL)
Title: Thienylacetic acid derivatives,their preparation and pharmaceutical compositions containing them
IPC: A61K31/381
Filed: 1990-03-14
Abstract: The present invention relates to thienylacetic acid derivatives of the general formula I   <IMAGE> (I)  in which X denotes -O- or -NH-; R1 denotes hydrogen, the group -CH2-CO-R3 or the group -CO-CH2-NH2; R2 denotes hydrogen, (C1-C4)-alkyl or the radical R1 and R3 denotes (C1-C4)-alkoxy, hydroxyl or amino, it not being possible for both R1 and R2 to represent hydrogen when X denotes O, as well as the pharmaceutically tolerated salts thereof, process for the preparation thereof, the use thereof, and pharmaceuticals containing these and the preparation thereof.
Patent FI-20030304-A0 (FI)
Inventor: SUOLAHTI YRJOE
IPC: B65B11/06
Filed: 2003-02-27
Abstract: The invention relates to a wrapping machine and/or top foil wrapping machine, comprising a machine frame (1) supported on a fixed base and comprising upright vertical columns (2); a lifting frame (3) arranged to be vertically movable upwards and downwards and guided by the vertical columns (2); a lifting motor (4) for moving the lifting frame, power transmission means for the transmission of power from the lifting motor to produce vertical motion of the lifting frame, said power transmission means comprising elongate flexible drive elements (5) and wheels for the transmission of the power of the lifting motor to the drive elements. The wrapping machine further comprises a foil dispenser (7), on which a foil web roll (8) can be rotatably supported. The top foil wrapping machine comprises a top foil depositor. The lifting motor (4) is secured to the lifting frame (3) so as to be movable with it. The wheels comprise a drive belt pulley (6) fitted for reeling a flat belt. The drive belt pulley (6) is rotatably mounted on bearings on the lifting frame (3) and rotated by the lifting motor (4). Each one of the elongate drive elements (5) consists of a drive belt whose first end (9) is secured to the upper end of the vertical columns while the second end (10) is secured to the drive belt pulley (6). <IMAGE>
Patent FI-20050412-A0 (FI)
Inventor: TÖRRÖNEN JUHA
IPC: H04L67/1023
Filed: 2005-04-21
Abstract: The invention relates to the multiplexing of transport layer connections in a communication system comprising a front-end node and a number of server nodes. A first packet from the server node is routed to the front-end node, the first packet comprising destination information associated with an external node. A termination point associated with the destination information is established in the front-end node. The application data from the first packet is provided to an application entity in the front-end node. The first packet is sent to the external node.
Patent FI-20096104-A0 (FI)
Inventor: NIITTYMIES HEIKKI
Filed: 2009-10-27
Abstract: The invention relates to arranging passage control for mining vehicles. A passage control apparatus is provided, preconfigured there to for use,with a set of movable passage control units. Each passage control unit (3) is provided with an identifier preconfigured therefor and arranged to be communicated to control means (20) of the passage control apparatus. The apparatus comprises a control user interface (23)configured to indicate (32)passage control units that, on the basis of identifiers received from at least some of the passage control units (3), are connected to the control means (20). The control means (20) are configured to assign (33) for passage control at least one passage control unit (3) from among the passage control units connected to the control means on the basis of an input received from a user. The control means are configured to monitor a passage control signal of the at least one passage control unit (3) assigned for passage control.
Patent IL-110051-A0 (IL)
Title: Carbo-acyclic nucleoside derivatives
IPC: C07D239/54
Filed: 1994-06-20
Abstract: The present invention is directed to a class of novel carbocyclic derivatives having formulas (I) and (II) and their use as anti-viral and anti-neoplastic agents, wherein X1 and X2 are each independently hydrogen, fluorine, or chlorine, R is hydrogen or hydroxymethyl, J is a radical of formulas (a), (b) and (c). Y1 is a CH group, a CCl group, a CBr group or a CNH2 group, Y2 and Y3 are each independently nitrogen or a CH group, Y1 is a CH group, a CCl group, a CBr group or a CNH2 group, Y2 and Y3 are each independently nitrogen or a CH group, Y4 is hydrogen, C1-C4 alkyl, C1-C4 alkoxy or halogen, Y5 is NH2 or C1-C4 alkoxy, Q is NH2, NHOH, NHCH3, OH, or hydrogen, and V is hydrogen, halogen or NH2; or a pharmaceutically acceptable salt thereof.
Patent IL-114200-A0 (IL)
Title: DNA encoding high-affinity melatonin receptors and uses thereof
IPC: G01N33/566
Filed: 1995-06-18
Abstract: Disclosed are cDNAs and DNAs encoding high-affinity melatonin 1a and 1b receptors and the recombinant polypeptides expressed from such cDNAs. The recombinant receptor polypeptides, receptor fragments and analogs expressed on the surface of cells are used in methods of screening candidate compounds for their ability to act as agonists or antagonists to the effects of interaction between melatonin and high-affinity melatonin receptor. Agonists are used as therapeutics to reentrain endogenous melatonin rhythms as a means of treating circadian rhythm disorders in humans and control reproductive cycles in seasonally breeding animals. Antagonists are used as therapeutics to control the initiation or timing of puberty in humans. Antibodies specific for a high-affinity melatonin receptor (or receptor fragment or analog) and their use as a therapeutic are also disclosed.
Patent IL-115202-A0 (IL)
Title: Blister package
IPC: B32B27/36
Filed: 1995-09-07
Abstract: The blister package for moisture sensitive pharmaceutical preparations has cavities (1) for the effective substance comprising preparations and cavities (2) for drying agents, whereby each cavity (1) for effective substance comprising preparations by a canal is connected with a cavity (2) for drying agents and the cover sheet (5) in the region of the cavities (2) for drying agents is thus enforced by an additional protection sheet (6) so that a withdrawing of the drying agent is excluded if usual means are applied.
Patent IL-124853-A0 (IL)
Title: Fungal food
IPC: C12N15/01
Filed: 1996-12-09
Abstract: PCT No. PCT/GB96/03046 Sec. 371 Date Jun. 12, 1998 Sec. 102(e) Date Jun. 12, 1998 PCT Filed Dec. 9, 1996 PCT Pub. No. WO97/22686 PCT Pub. Date Jun. 26, 1997A human food product comprises a higher ploidy strain of Fungi imperfecti of which each parent has a genetic growth constraint not shared by the other parent. One parent is for example auxotrophic for two compounds selected from histidine, arginine, leucine and adenine and the other for the other two. The nucleic acid content of the strain is preferably less than 2% by weight. The strain may be made by killing a higher ploidy strain of Fungi imperfecti and simultaneously reducing its nucleic acid content to below 2% by weight by treatment with water. The process may include preparing a higher ploidy strain of edible Fusarium by culturing two auxotrophs thereof together in a medium containing nutrients permitting both to grow and then culturing organisms derived from such culture in minimal medium. The invention is applicable to the production of human food by culturing the strain in conditions such that reversion or partial reversion to the haploid form(s) is minimised.
Patent IL-137746-A0 (IL)
Title: Diisopropyl fluorophosphatase and the utilization and production thereof
IPC: C02F3/00
Filed: 1999-02-23
Abstract: The present application relates to a diisopropyl-fluorophosphatase from Loligo vulgaris, and to the amino acid and nucleic acid sequences encoding the enzyme. Also provided are vectors which contain the DNA sequence according to the invention, and to cells transformed with the base sequence according to the invention. Finally, the present application also provides a method for the production of the diisopropyl-fluorophosphatase and various types of use and areas of employment of the diisopropyl-fluorophosphatase, in particular the decontamination of contaminated habitats, the production of medicinal products for treating or detoxifying humans and animals, the impregnation of clothing and the use in analyses.
Patent IL-143123-A0 (IL)
Title: Methods for the preparation of nucleic acid and polypeptide libraries and uses thereof
IPC: C12N15/10
Filed: 1999-11-18
Abstract: This invention provides novel methods of generating large, highly diverse, nucleic acid (and hence polypeptide) libraries. The methods exploit the discovery that recombination, particularly recombinase recombination can occur between two or more constructs of the same type (e.g. having the same origin of replication and/or the same regulatory or selectable markers). The methods thus involve introducing at least two members of an initial population of nucleic acid molecules into at least one cell under conditions were recombination (e.g recombinase mediated recombination) can occur between the nucleic acids. The nucleic acid molecules preferably comprise two or more individual nucleic acids each of which consists of a nucleic acid sequence that is identical for each molecule and that includes an origin of replication; and a nucleic acid sequence that varies between members of said population. Thus, a single type of construct is capable of mediates all of the recombination events providing substantially greater efficiency and the creation of substantially larger and more diverse nucleic acid libraries.
Patent IL-149744-A0 (IL)
Title: A body formed of set, initially pasty material and including an electrically conducting path and a method of making such a body
IPC: B28B1/08
Filed: 2000-12-21
Abstract: A body ( 5 ) of set, initially pasty material, such as concrete, includes an electrically conducting path formed by a concentrated layer ( 6 ) of electrically conducting magnetizable elements, such as fibers (F) or granules (G), embedded in the initially pasty material and extending through at least a portion of the body ( 5 ). Electrically conducting terminal members ( 9 ) may be connected to the electrically conducting layer ( 6 ) at spaced-apart positions along the layer ( 6 ). A method of providing such a body ( 5 ) includes the steps of: (a) forming a body of the pasty material in which electrically conducting magnetizable elements (F) are dispersed, (b) applying a magnetic field to the body of pasty material to form from the magnetizable elements an electrically conducting layer embedded in the body of pasty material and extending at least through a portion the body ( 5 ), and (c) causing the body of pasty material containing the layer ( 6 ) to set. Before or after the setting of the body ( 5 ) of pasty material, electrically conducting terminal members ( 9 ), may be connected to the electrically conducting layer ( 6 ) at spaced-apart positions along the layer.
Patent IL-158935-A0 (IL)
Title: Biodegradable biaxially drawn film with controlled tear resistance
IPC: C08L67/04
Filed: 2002-05-31
Abstract: The invention relates to a film with controllable tear resistant properties, comprising at least one basic layer which contains at least one polymer I from at least one hydroxycarboxylic acid, and >0.1 wt. %, in relation to the weight of the layer, of a thermoplastic polymer II which is different from polymer I, and/or inorganic additives.